Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study

被引:1
作者
Bjornsson, Oddur [1 ]
Jonsson, Eirikur [1 ]
Gudmundsson, Eirikur Orri [1 ]
Marteinsson, Valur Thor [2 ]
Nikulasson, Sigfus Thor [3 ]
Gudjonsson, Sigurdur [1 ]
机构
[1] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland
[2] Akureyri Hosp, Dept Surg, Akureyri, Iceland
[3] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
关键词
Upper tract urothelial carcinoma; nephroureterectomy; bladder recurrence; survival; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; BLADDER-TUMORS; PREVENTION; PREDICTORS; RECURRENCE; SURVIVAL; OUTCOMES; TRIAL;
D O I
10.1080/21681805.2021.1916073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective Radical nephroureterectomy is the standard treatment of organ-confined upper tract urothelial carcinoma (UTUC). The objective of this study was to investigate survival and bladder recurrence rate in Icelandic patients with UTUC who underwent radical nephroureterctomy (RNU) or other procedures with curative intent. Material and methods All patients who were diagnosed with UTUC in Iceland from 2003 to 2016 and treated with curative intent were included in the study. Information on patients was obtained retrospectively from patients' medical records and from the Icelandic Cause of Death Registry. Results Overall 63 patients underwent a procedure for UTUC with curative intent in Iceland during the study period. The median age was 71 years and the majority were male (65%). In 50 patients (79%), the tumor was a primary UTUC. The most common procedure was RNU (78%) and eight patients (13%) underwent a kidney-sparing procedure. No patient died within 90 d of surgery. Twenty-eight patients (44%) had pathological stage T2 or higher, whereas 35 patients (56%) had pathological stage T1 or lower. The median follow-up time was 98.8 months . During the follow-up time 25 patients (40%) were diagnosed with recurrence in the bladder. Five-year cancer-specific survival (CSS) was 67%. Conclusions This population-based study shows that the oncologic outcome in Icelandic patients with UTUC is similar to what has been reported in other countries. Bladder recurrence rate is high and can hopefully be reduced by improvements in surgical and intravesical instillation treatment. Possibly more kidney-sparing surgeries could have been done during the study period; however, careful selection for those procedures is mandatory.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 50 条
  • [21] Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy
    Moschini, Marco
    Foerster, Beat
    Abufaraj, Mohammad
    Soria, Francesco
    Seisen, Thomas
    Roupret, Morgan
    Colin, Pierre
    De la Taille, Alexandre
    Peyronnet, Benoit
    Bensalah, Karim
    Herout, Roman
    Wirth, Manfred Peter
    Novotny, Vladimir
    Chlosta, Piotr
    Bandini, Marco
    Montorsi, Francesco
    Simone, Giuseppe
    Gallucci, Michele
    Romeo, Giuseppe
    Matsumoto, Kazumasa
    Karakiewicz, Pierre
    Briganti, Alberto
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (10) : 1541 - 1547
  • [22] Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population
    Zeng, Shuxiong
    Zhang, Zhensheng
    Xu, Chuanliang
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (04) : 573 - 574
  • [23] External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study
    Xylinas, Evanguelos
    Kluth, Luis
    Rieken, Malte
    Roupret, Morgan
    Al Awamlh, Bashir Al Hussein
    Clozel, Thomas
    Sun, Maxine
    Karakiewicz, Pierre I.
    Gonen, Mithat
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (01) : 33.e21 - 33.e26
  • [24] Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need
    Azizi, Mounsif
    Cheriyan, Salim K.
    Peyton, Charles C.
    Foerster, Beat
    Shariat, Shahrokh F.
    Spiess, Philippe E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (05)
  • [25] Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives
    Leow, Jeffrey J.
    Liu, Zhenbang
    Tan, Teck Wei
    Lee, Yee Mun
    Yeo, Eu Kiang
    Chong, Yew-Lam
    ONCOTARGETS AND THERAPY, 2020, 13 : 1 - 14
  • [26] Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma
    Milojevic, Bogomir
    Dzamic, Zoran
    Kajmakovic, Boris
    Durutovic, Otas
    Bumbasirevic, Uros
    Grujicic, Sandra Sipetic
    CLINICAL GENITOURINARY CANCER, 2015, 13 (05) : 485 - 491
  • [27] Risk of acute myocardial infarction in upper tract urothelial carcinoma patients receiving radical nephroureterectomy: a population-based cohort study
    Lin, Shih-Yi
    Lin, Cheng-Li
    Chang, Chao-Hsiang
    Wu, His-Chin
    Wang, I-Kuan
    Chou, Che-Yi
    Liang, Ji-An
    ONCOTARGET, 2017, 8 (45) : 79498 - 79506
  • [28] Nomograms to predict overall and cancer-specific survival in patients with upper tract urothelial carcinoma: a large population-based study
    Qi, Feng
    Wei, Xiyi
    Zheng, Yuxiao
    Sha, Yeqin
    Lu, Yousheng
    Li, Xiao
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1177 - 1191
  • [29] Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan
    Chen, Jeng-Sheng
    Lu, Chin-Li
    Huang, Li-Chung
    Shen, Cheng-Huang
    Chen, Solomon Chih-Cheng
    MEDICINE, 2016, 95 (14)
  • [30] Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017
    van Doeveren, Thomas
    van der Mark, Marianne
    van Leeuwen, Pim J.
    Boormans, Joost L.
    Aben, Katja K. H.
    BJU INTERNATIONAL, 2021, 128 (03) : 343 - 351